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ABSTRACT 
The Effects of Chronic Stress and Exercise on Mouse Pancreatic 
Islet of Langerhans Morphology and Muscle Atrophy Gene 
Expression 
Travis Parkulo 
 
Chronic stress has been implicated as a possible contributing factor to the onset of Type 2 
Diabetes Mellitus through its negative effects on peripheral insulin sensitivity and the insulin 
producing β cells of the pancreas. Exercise could serve as a possible countermeasure to the 
damaging effects of chronic stress due to its proven ability to increase insulin sensitivity at the 
level of the muscle and improve or maintain β cell function and mass. To date, no published 
research has examined the effects of chronic stress in combination with voluntary wheel running 
on murine islet morphology and skeletal muscle atrophy. The purpose of this study was to 
evaluate the effects of chronic stress and voluntary wheel running on murine beta cell number 
per Islet, insulin positive area in the pancreas, hind limb skeletal muscle morphometrics, 
autophagy protein expression, and muscle atrophy gene expression. 40 Male Balb/c mice were 
randomized into 4 groups; sedentary (N=10: Sed), sedentary stressed (N=10: SedSt), exercise 
(N=10: EX), and exercise stressed (N=10: EXSt). 20 mice were given free access to running 
wheels over 4 weeks after which, 10 were randomized to 7 hrs/d, 5 d/wk. of stress for 8 wks. 20 
mice remained sedentary with no access to running wheels; after 4 weeks 10 of these mice were 
randomized to 7hrs/d, 5d/wk. of stress for 8 wks.  The average islet area was significantly 
increased in ExSt (24223.810 ± 2670) when compared to Ex mice (16811.00 ± 2704) (P < .05). 
Average β cell number per islet was significantly higher in ExSt (93.21± 5.69) and SedSt 
(90.99± 5.22) mice when compared to Ex (68.64± 3.73) or Sed  (70.73 ± 4.77) (P < .05).  Muscle 
wet weight was increased in EXSt mice vs. SedSt mice (P < .05). These results indicate that 8 
iii 
 
weeks of chronic stress caused β cell proliferation and an increase in islet area, but did not result 
in an increase in muscle ubiquitin associated atrophy gene mRNA levels. Exercise coupled with 
stress appeared to improve muscle protein accumulation and therefore, could be a potential 
means to reduce muscle losses under conditions of high stress or β cell dysfunction. 
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ABREVIATIONS  
T2DM Type 2 Diabetes Mellitus  
HPA Hypothalamic Pituitary Adrenal Axis  
GC Glucocorticoid  
IR Insulin Receptor  
IRS-1 Insulin Receptor Substrate 1  
MuRF-1 Muscle Ring Finger 1 
MAFbx Muscle Atrophy F-box  
CMS Chronic Mild Stress 
CRF Corticotrophin Releasing Factor  
CRH Corticotrophin Releasing Hormone 
AVP Arginine-Vasopressin 
ACTH Adrenocorticotropic Hormone  
GR Glucocorticoid Receptor 
PVN Paraventricular Nucleus   
PFC Prefrontal Cortex  
UPS Ubiquitin Proteolysis System  
GSIS Glucose Stimulated Insulin Secretion  
ZDF Zucker Diabetic Fatty  
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CHAPTER 1. INTRODUCTION 
1.1. Background and Significance 
Type 2 Diabetes Mellitus (T2DM) is a metabolic disorder in which insulin resistance 
occurs in the peripheral tissues causing a disruption in the uptake and storage of fuel substrates 
1
. 
T2DM is reaching epidemic proportions and the prevalence of the disease is on the rise. By the 
year 2030 it is projected that 439 million people worldwide will be living with diabetes 
2
. The 
cause of this increase in diabetes prevalence is likely due to an aging population and an increase 
in overall population size 
3
. In addition; obesity, increasing sedentary lifestyles and poor dietary 
choices are known to cause metabolic disturbances that lead to T2DM 
4
.  
Increasing evidence has indicated that prolonged stress could be another contributing 
factor to the onset of T2DM, through increased activation of the hypothalamic-pituitary-adrenal 
(HPA) axis causing increased levels of stress hormones 
5
. Psychological stress has long been 
suspected of being linked with diabetes development 
6
. Anxiety and depression are known to 
increase the risk of acquiring T2DM 
7,8
. Often depressed patients have increased levels of 
cortisol
9
 and chronically high glucocorticoid (GC) levels cause enhanced hepatic 
gluconeogenesis, increased circulating glucose levels, protein degradation, and antagonize the 
effects of growth hormone and insulin 
10
 
5
. 
 Along with changes to peripheral tissues, GC’s also stimulate the insulin producing β-
cells that are located in the islets of Langerhans to increase their mass in order to maintain 
glucose homeostasis 
11
. This increase in β-cell mass is a healthy response to various stimuli that 
cause an increased glucose challenge and is called compensation 
12
. β-cell compensation is often 
seen in obese individuals and β-cell mass can reflect whole body adiposity and insulin resistance 
11
. β-cell mass increases are due to individual β-cells increasing their size and/or cell 
regeneration within the islet 
12
. Within a healthy islet, β-cell mass is maintained through a 
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continuous balance of cell replication, neogenesis, and apoptosis 
11
. If this balance becomes 
abnormal or compensation continues for an extended period of time β-cell dysfunction could 
occur, resulting in a reduction in β-cell mass through apoptosis 13 or exhaustion of insulin release 
12,14. Individuals that have dysfunctional β-cells could be diagnosed as pre-diabetic; with 
prolonged dysfunction resulting in T2DM 
12,15
. The mechanisms leading to dysfunction from 
compensation are not fully known, however, increased exposure to free fatty acids and glucose 
have been shown to affect β-cell function, both of which are influenced by GCs and physical 
activity levels 
16–18
. 
GCs exert metabolic effects throughout the periphery on numerous different target 
tissues, including skeletal muscle
19
.  Skeletal muscle contributes to maintaining euglycemia by 
serving as a glycogen reservoir. In times of stress, GCs may be released in excess which could be 
detrimental to skeletal muscle by inducing muscle atrophy and insulin resistance
19
. GCs cause an 
altered translocation of GLUT-4 in skeletal muscle which inhibits glucose uptake and glycogen 
synthesis 
20–22
. Insulin signaling is also interrupted by excess GCs as evidenced by reduced 
insulin receptor (IR) and insulin receptor substrate 1 (IRS-1) proteins in mouse muscle treated 
with GCs 
21
. Furthermore, the activity of phosphoinositide-3-kinase (PI3K) and Akt, which serve 
as downstream signaling molecules to IR and IRS-1 exhibit reduced activity 
21,23,24
. Protein 
degradation occurs in parallel to the insulin signaling defects as a result of excess GCs. 
Numerous studies have demonstrated that treating animals with synthetic GCs results in a 
reduction of muscle mass 
25–28
. There are a number of genes that have been discovered to be 
upregulated during times of muscle wasting that are called atrogenes 
29
. Muscle RING finger 1 
(MuRF1) and muscle atrophy F-box (MAF-bx) are well known atrogenes and have increased 
gene expression during many muscle wasting situations including T2DM 
30
. Furthermore, during 
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synthetic GC injection , there are increases in levels of the autophagy proteins that along with the 
atrogenes could contribute to increased muscle atrophy
31
.  
Exercise training has long been established as having protective effects against T2DM 
development and has been shown to reduce the risk of T2DM in both humans 
32–34
 and rodents 
35–37
. Regular exercise increases GLUT-4 translocation in working skeletal muscle which 
promotes maintenance of normal glucose levels 
38
. Increases in muscle insulin sensitivity are also 
seen with regular exercise, which decreases the amount of insulin that needs to be released by the 
β-cells. It has been hypothesized that these changes to skeletal muscle prevent β-cell exhaustion 
by means of preserving β-cell mass 11. In addition to effects on β-cells, regular exercise is known 
to upregulate the Akt/mTOR pathway thus inhibiting skeletal muscle proteolysis and preventing 
muscle wasting
39
. 
Increased GC levels have been induced through the use of synthetic dexamethasone or 
exogenous GCs in order to elucidate their effects 
21,22,40
. A possible alternative model to induce 
increased levels of circulating GCs and mimic a prediabetic state is through the use of a Chronic 
Mild Stress (CMS) model. CMS has been shown to cause anxiety, depression, increased levels of 
corticotrophin releasing factor (CRF), increased circulating corticosterone and glucose 
intolerance
41,42
. Through the use of a CMS model this thesis seeks to examine the effect of stress 
on β cell morphology and skeletal muscle. In addition to this, exercise has been shown to provide 
many positive counter effects to increased circulating GCs and will be examined in combination 
with CMS to determine if it can serve as an effective counter measure to the detrimental effects 
of stress.   
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1.2. Purpose and Specific Aims  
To date no research has been published that determines to what extent a method of 
stressing animals, such as Chronic Mild Stress (CMS) model, effects β cell morphology and 
muscle atrogene expression. In addition, the effects of CMS and voluntary exercise administered 
in combination are largely unknown. The purpose of this thesis is to examine the combined 
effects of CMS and exercise on β cell morphology and skeletal muscle atrophy and 
autophagy.  
 
Specific Aim 1. Determine the effect of 8 weeks of CMS and exercise on pancreatic β cell 
morphology. 
Hypothesis 1.  CMS alone will cause an increase in β-cell number per islet and islet area.  
Hypothesis 1.2. CMS in combination with exercise will result in an attenuation of β cell number 
and islet area increases. 
Specific Aim 2. Determine the effect of 8 weeks of CMS and exercise on muscle atrophy and 
ubiquitin proteolysis gene expression.  
Hypothesis 2.1. CMS alone will cause an atrophic effect, thus reducing muscle mass and 
causing an increase in gene expression of the muscle atrophy associated genes Murf-1 and 
MAFbx. 
Hypothesis 2.2. CMS in combination with exercise will prevent a loss in muscle mass and will 
attenuate MuRF-1 and MAFbx gene expression. 
Specific Aim 3. Determine the effect of 8 weeks of CMS and exercise on protein markers of 
autophagy; Beclin-1, ATG-7 and LC3a/b.  
Hypothesis 3.1 CMS alone will cause an increase in all measured autophagy protein markers.  
5 
 
Hypothesis 3.2. CMS in combination with exercise will prevent a loss in muscle mass and will 
have attenuated Beclin-1, ATG-7 and LC3a/b levels.  
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CHAPTER 2. REVIEW OF LITERATURE  
2.1 Stress response  
Stress and anxiety have been shown to be possible factors for increased risk of T2DM, 
due to the accompanying metabolic disturbances they cause 
43
. A wide range of stressful 
situations like chronic work stress, low socioeconomic status
44,45
, anxiety, and depression
46
, 
could potentially elicit undesirable neuroendocrine responses. Hans Selye a pioneer in 
determining the physiologic response to stress, defined stress as ‘‘the nonspecific response of the 
body to any demand’’47. Stress can be broadly categorized into 3 categories: 1) psychological 
stressors (fear, anxiety, exposure to a novel or uncontrollable environment); 2) stressors 
combining a physical stimulus with a strong psychological component (pain, foot shock, 
immobilization); 3) challenges to cardiovascular homeostasis (hemorrhage, exercise, heat 
exposure, orthostatic stress/upright tilt)
48
. When presented with various stressors that become a 
threat to homeostasis a healthy individual will respond by activation of the stress response 
49,50
. 
The stress response can occur through behavior modification, increased neural output, increased 
secretion of hormones or a combination of all three
49
. There are two main brain circuits that 
initiate and maintain the stress response system; the hypothalamic pituitary adrenal (HPA) axis 
and the sympathetic nervous system
51
. These circuits are located and centrally mediated through 
the hypothalamus and the brainstem
52
 and ultimately influence the level of glucocorticoids that 
will be released into the systemic circulation.   
HPA Axis  
Under basal conditions the hypothalamus secrets corticotrophin releasing factor (CRH) 
and arginine-vasopressin (AVP) into the hypophyseal portal system, in a diurnal pulsatile fashion 
with a burst of secretion every 2-3 hours
52
. These two hormones function synergistically, with 
AVP causing increased release of CRH. The peak release levels in humans occur in the early 
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morning hours and decrease throughout the day. In rodents this release cycle is opposite due to 
their nocturnal nature and their levels peak at night and decrease as the night goes on into the 
early morning hours. When faced with a stressor the system is activated quickly and peak GC 
release occurs in 15 to 30 minutes with a gradual wane in release lasting up to two hours post 
stressor 
53
. Influences such as lighting, food intake, activity levels, and stressful situations can 
alter the pulsatile release schedule of CRH and AVP thus altering adrenocorticotropic hormone 
(ACTH) release from the anterior pituitary
52
.  
When challenged with a stressful situation or through psychological preparation for an 
upcoming high stress event, the HPA axis is rapidly activated and has far reaching effects 
throughout the body. These far reaching effects are mainly due to the abundance of the 
glucocorticoid receptor (GR)
53
. The hypothalamus mediates the stress response through the 
release of corticotrophin releasing hormone (CRH) which stimulates the anterior pituitary to 
release ACTH. Circulating ACTH is a key regulator of the release of glucocorticoids from the 
adrenal cortex. The subsequent release of GCs, mainly cortisol in humans and corticosterone in 
rodents, from the adrenal glands, is essentially the final product of the HPA axis. Upon exerting 
its effects throughout the animal, cortisol also functions as a potent inhibitor of further anterior 
pituitary release of ACTH, thus inhibiting further cortisol release. The inhibitory function of 
cortisol is critical in order to prevent long exposure to increased glucocorticoid levels which 
could be harmful due to their catabolic, anti-reproductive and immunosuppressant effects
53
. The 
binding of GC to GR in the prefrontal cortex and hippocampal brain regions serves as a braking 
system to HPA axis activation. The HPA axis is critical for survival and adaptation, healthy 
individuals will respond to the increasing levels of glucocorticoids in a concentration dependent 
manner that results in an “inverted U-shape” graph when glucocorticoid levels are plotted against 
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level of adaptation (see figure below)
54
. Counter to this, too much GCs without a properly 
functioning inhibitory feedback system can lead to many detrimental effects. 
 
Dysfunction of the HPA 
The stress response and its effectiveness are highly temporal in nature with its subsequent 
activation meant to last only for an acute time frame. Chronic activation of the HPA can result in 
detrimental effects such as; anti-reproduction, catabolism, and immunosuppression
52
. It is critical 
to understand that when an organism is faced with chronic stress there is a cross over from 
adaptive response to a maladaptive response. These maladaptive responses are believed to be the 
result of chronic stress causing a major structural shakeup in the workings of the HPA axis. 
Chronic stress can lead to hyperactivation of the HPA with increases seen in CRH and AVP in 
paraventricular nucleus (PVN) neurons
53
. Accompanying the hyperactivation of the stress 
response is a diminished inhibition effect. The HPA axis in healthy individuals is rapidly 
inhibited by the rising levels of GC that bind to GR in the prefrontal cortex (PFC) and 
hippocampus. Glucocorticoids injected directly into the PFC result in decreased HPA axis 
activity
55
. In a maladaptive state, which features times of chronic activation of the HPA, the GR 
expression levels in the prefrontal cortex and hippocampus have been shown to be reduced
56
. 
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There is also evidence that as the HPA axis becomes dysfunctional through chronic activation 
there could be a feed forward mechanism at work which would cause a maladaptive response to 
stress. This feed forward mechanism is believed to occur in the central nucleus of the amygdala 
which serves to inhibit the inhibitory relay neurons signaling the PFC
53
 in times of chronic stress. 
The end result of the dysfunctional responses of the HPA in times of chronic stress is an increase 
in the amount of circulating GCs.  
2.5 The chronic mild stress model   
 The CMS model was developed by Wilner and colleagues in order to create an animal 
model that is a valid simulation of a chronic state of depression
57
. The CMS model features 
various mild stressors (predator noises, constant cage shaking, damp bedding, no bedding, water 
in the cage, tilted cage and altered light dark cycle) applied every few hours and repeatedly over 
the course of weeks or months. The CMS model has proven its ability to serve as a valid model 
for animal depression. Much of this validity is based upon the CMS models ability to induce 
anhedonia in rodents
57
. Anhedonia is the lack of responsiveness to pleasurable events; this is 
measured in the CMS model through rodent’s sucrose preference in drinking water57. CMS has 
been used extensively in the study of the effectiveness of current antidepressive drugs and the 
discovery of new antidepressive treatment
57
. CMS has been shown to cause increased levels of 
corticotrophin releasing factor (CRF), increased circulating corticosterone and glucose 
intolerance
41,42
.  An additional use of CMS could be to examine the association among 
depression and T2DM. It has been found that there is a bidirectional relationship between 
depression and T2DM with depressed individuals having increased incidence of diabetes and 
vice versa
7,8
.  
 Phenotypically rodents subjected to CMS typically show a reduced coat state, which is a 
score of 1-4  given to each animal by two independent observers and is based on the overall state 
10 
 
of the animals coat
41,58
. In addition, the sex and strain of the mouse is also highly important as 
different strains will adapt more favorably or less favorably throughout the time course of the 
study
58
. It has been previously shown that male C57Bl/J6 mice have the greatest outward 
detrimental effect to the fur which is indicative of increased stress
58
. This indicates that not all 
mice will respond to the same degree to CMS and that care should be taken when choosing a 
strain so that the stress will provide maximal effect.  
Glucocorticoid relationship to metabolic pathologies 
Genetic and environmental factors can cause alterations in GR function and result in GC 
resistance. Possible environmental factors that lead to GC resistance would include chronic 
inflammation, exposure to infectious agents, chronic exposure to exogenous glucocorticoids 
(dexamethasone), and chronic stress exposure
59
. There has been a suspected link between stress 
and metabolic disorders for quite some time. Acute stress as mentioned before causes elevations 
in GCs which help an organism regain homeostasis. However, with an increased timeframe of 
stress and the introduction of chronically high GC levels, dysfunction can arise in the GC/GR 
signaling complex which can lead to detrimental effects for the organism as a result of 
glucocorticoid resistance
59
.  Increased stress levels and elevated GCs in humans have been 
convincingly linked to coronary heart disease
60
. There could also be an association between 
stress and metabolic syndrome or even T2DM
61
. Metabolic syndrome presents as hyperglycemia, 
abdominal obesity, elevated triglycerides, and high blood pressure
43
. These abnormalities are 
also known to occur in Cushing’s syndrome in which individuals are over producing cortisol. 
Thus many studies have tried to focus on the pathogenesis of metabolic syndrome and how stress 
or alterations in GC levels can cause individuals to exhibit a metabolic syndrome like state. 
Many individuals who present with metabolic syndrome have been found to have a hyperactive 
11 
 
HPA axis and hypercortisolism
43
. This hypothesis has been very difficult to confirm due to the 
many factors contributing to the stress response and differences between how individuals 
respond to stress. Nonetheless, it has been found that cortisol controls many aspects of adipose 
tissue and when in excess can cause visceral adiposity
62
. Excessive GC levels promote 
lipoprotein lipase which results in the increase in circulating FFA, accumulation of triglycerides 
in adipocytes, and possible lipotoxicity in peripheral tissues
63
. Continual metabolic effects of 
chronically elevated GCs could promote a vicious cycle of inflammation, a contributing factor in 
the pathogenesis of metabolic syndrome. The increased cytokines from this state could lead to 
symptoms in which an organism is shifted toward behavioral depression with reduced locomotor 
activity and increased sleep; in order to conserve energy for further immune activation
59
. 
Metabolically, chronically elevated GCs cause a multitude of problems which can lead to 
pathologies if not treated. In addition to the metabolic effects of elevated GCs, they also exert 
their effects on two important tissues that serve as the main pathological focus of the occurrence 
of T2DM; muscle and pancreatic β cells. The effect of chronically activated HPA and increased 
GC levels and their direct and indirect effect on these two tissues will be covered in the 
following sections.   
Direct Effect of GCs on Muscle  
 Skeletal muscle is unique in that much like the liver, it serves as a large glucose storage 
depot helping to prevent hyperglycemia. Skeletal muscles role in glucose metabolism is critical 
as it is accountable for 80% of postprandial glucose uptake from the circulation
64
. The glucose 
storing capacity of muscle can be negatively affected when there is insulin insufficiency or 
disruptions in insulin signaling. This was first observed over 75 years ago by Sir Harold 
Himsworth who discovered a large number of patients with diabetes were “insulin insensitive”65.  
GCs effect on muscle glucose uptake can be most clearly seen in cases where GCs are in excess 
12 
 
such as exogenous administration or Cushing’s syndrome. Henriksen et al. demonstrated this by 
administering exogenous GC (dexamethasone) to healthy subjects over a 5 day period and 
observed reduced glycogen synthesis rates and decreased glycogen synthase concentrations and 
activity within skeletal muscle
66
. Further GC treated skeletal muscle alterations were shown by 
Tomlinson et al. who showed reduced expression and phosphorylation of insulin receptor 
substrate-1 (IRS-1), phosphatidylinositol 3-kinase (PI3-k), and protein kinase b (PKB)/Akt and 
the translocation of GLUT-4 to the cell surface
21
.  
 In addition to the altered glucose homeostasis present during excessive levels of GCs in 
skeletal muscle, there is also an increase in skeletal muscle atrophy. Atrophy of skeletal muscle 
is characterized by a decrease in the size of muscle fibers. There are a number of pathological 
states in which muscle atrophy occurs and is associated with an increase in circulating GC levels 
(sepsis, cachexia, starvation, metabolic acidosis, and severe insulinopenia)
67
. Elevations in 
circulating levels of GCs increase protein breakdown and decrease protein synthesis. In animal 
models of GC induced atrophy, the age of the animal plays a role in whether increased protein 
breakdown or decreased protein synthesis will result in atrophy. Dardevet et al. found that in 
adult rats increased protein breakdown led to atrophy whereas aged rats saw depressed protein 
synthesis
68
. 
 Glucocorticoids stimulate skeletal muscle atrophy through the activation of the ubiquitin 
proteasome system (UPS), the lysosomal system (autophagy) or the calcium dependent system 
(calpains)
67
. It was discovered by Tiao et al. that protein degradation due to GCs mainly causes 
degradation of the myofibrillar proteins and extracellular matrix proteins. The ubiquitin 
proteasome system is known to degrade protein through two steps: 1) tagging the substrate by 
covalent attachment with many ubiquitin molecules and 2) degradation of the tagged protein by 
13 
 
the 26S proteasome complex with recycling of ubiquitin
69
.   Of importance for this thesis, GC 
have been linked to the expression of several components of the UPS namely the atrogenes, 
MuRF-1 and MAFbx also known as Atrogin-1
29
. Furthermore, GC are directly involved in 
upregulating proteasome activity
70
. The atrogenes MuRF1 and MAFbx are muscle specific E3 
ubiquitin-ligases and are increased in most catabolic scenarios, including denervation, nutritional 
deprivation, unloading and exogenous GC treatment
19
. These E3 ubiquitin-ligases are the 
mediators of the ubiquitination process that occurs prior to degradation by the 26S proteasome. 
MuRF-1 and MAFbx knockout (KO) animals have been used to determine if muscle mass loss 
can be attenuated when muscles are denervated. Bodine et al. found that during denervation, the 
KO animals did have attenuations in muscle mass loss, however when exposed to exogenous GC 
only MuRF-1 KO’s and not MAFbx KO had attenuated muscle atrophy29. Additionally MuRF-1 
has been shown to play a role in myosin heavy chain ubiquitination and degradation during 
dexamethasone treatment
71
. These atrogenes are thought to be regulated through the increased 
expression of FOXO1 and FOXO3α, whose transcription is regulated by GC. The involvement 
of FOXO1 transcriptional activation by GC has been shown in vitro, but there is not yet direct in 
vivo evidence for the necessity of FOXO to be involved in GC related muscle atrophy.  
2.3 Autophagy  
 Classically, autophagy’s function has been known to degrade cytoplasmic components, 
protein aggregates, and/or organelles, serving as a tool for nutrient breakdown and a means to 
regulate the cellular architecture
72
. This occurs through the sequestration of the worn out 
cytoplasmic organelles in a vacuole called the autophagosome. Following the sequestration, the 
autophagosome fuses with a lysosome that degrades the vacuole products by lyososomal 
hydrolases
73
.  Autophagy is crucial for survival as whole body KO of autophagy protein 12 
(ATG-12) in mice has proven to be lethal
74
. Skeletal muscle cellular components are frequently 
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being damaged due to the high amounts of reactive oxygen species produced within the muscle. 
Autophagy serves as a cellular remodeling agent providing a route for damaged or worn out 
organelles to be recycled and also serves to provide energy needs of the body through the 
breakdown of protein
72
. There is recent evidence that suggests there is a possible link between 
autophagy and GC induced muscle atrophy.  GC induced muscle atrophy has been discovered to 
be mediated not only through the UPS, but possibly through autophagic-lysosomal proteolysis
75
.  
 The proposed link between GC and skeletal muscle autophagy has been made through the 
FOXO3α pathway76. This is of interest because FOXO3 drives the expression of autophagic 
genes such as microtubule-associated protein 1 light chain 3 (LC3), vacuolar protein sorting 
(Vps34), Atg12, and GABA(A) receptor-associated protein (GABARAP)
72
. Following the 
activation of FoxO3 by GC the Atg proteins and other cellular pathways control autophagy 
which is broken down into three steps: 1)initiation, 2) nucleation/autophagosome formation, and 
3) lysosome fusion/degredation
72
. Initiation is mediated through ULK1 not being phosphorylated 
by mTOR which allows ULK1 to initate phagophore nucleation. Initiation can also occur 
through interactions of Bcl-2 and the Beclin-1 initiation complex
72
. The nucleation of the 
phagophore is occurring due to the complexation of Beclin-1 with various autophagy proteins 
(Atg14, Vps15, UVRAG, Rubicon, class III PI3K)
72
.  This Beclin-1 complex produces the 
nucleating lipid species PI3P which results in elongation of the phagophore. Nucleation also 
involves the E1 and E2 ubiquitin ligases, Atg7, and Atg10
72
. Furthermore there is involvement of 
Atg5 being conjugated to the ubiquitin like Atg12 and conjugation of phosphatidylethanolamine 
to LC3I to form Atg8/LC3II. The mature autophagosome is now able to sequester cytoplasm, 
proteins, and organelles, for their subsequent delivery to the lysosome where they are degraded. 
The levels of LC3I to LC3II and also increased Beclin-1 levels have been used as indicators of 
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autophagy induction
72
.  Although autophagy is considered a good thing in healthy and well-
functioning muscle, few studies have examined the effect that autophagy plays in a muscle 
wasting model such as cancer or dexamethasone administration. One of the few studies to do so 
was Penna et al. who examined autophagy proteins involved in dexamethasone injected mice and 
C26 tumor bearing mice. Following just 7 days of dexamethasone injection the levels of Beclin-1 
and LC3B were significantly increased in the tibialis anterior along with overall losses in skeletal 
muscle mass
31
. These results indicate that autophagy could contribute to skeletal muscle atrophy 
in a model of dexamethasone injection or elevated GC levels. 
2.4 Direct and indirect effects of GCs on Islet morphology and function  
 The β cells of the islet of Langerhans are essential for maintaining euglycemia. 
Euglycemia is maintained by β cells releasing insulin in response to rising blood glucose levels. 
Insulin release occurs in two phases with the first phase occurring 8-10 minutes after a meal is 
ingested
77
. This is followed by a longer lasting second phase that occurs 30-45 minutes after 
meal ingestion
78
. Impairment of beta cell function is clinically considered pre-diabetes if the 
blood glucose levels are not lowered to basal levels within 2 hours following a meal
11
. The 
increased time course to lower blood glucose could be due to β cell dysfunction, characterized by 
β cells themselves becoming desensitized to glucose or insulin signaling11.  
 β cell mass is in a dynamic balance in the healthy non-diabetic individual due to ever 
changing levels of β cell apoptosis, replication, and neogenesis11. β cell mass is highly important 
due to its reflection of whole body adiposity and insulin resistance
11
. Naturally if the delicate 
balance between apoptosis, replication and neogensis is disrupted pathologies could arise. It has 
been found by Butler et al. that T2DM patients have increased levels of apoptosis occurring in β 
cells
13
. Apoptosis is necessary for healthy β cell mass expansion; however when present in 
exceeding amounts can greatly reduce the ability of the β cells to produce the correct amount of 
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insulin. As the pathology of T2DM arises the β cells are thought to go through a cycle of 
compensation which entails their expansion due to the increased peripheral insulin resistance, 
thus stimulating them to proliferate or increase in individual size, resulting in more insulin 
production. Following this expansion phase of the cycle is the phase Beaudry et al. terms 
dysfunction. This phase is characterized by reduced insulin release although some individuals are 
able to maintain euglycemia and not become hyperglycemic
79
.  Subsequently, the β cells become 
reduced in mass. It is hypothesized that this is what Butler et al. observed in their study of T2DM 
patients. At this point of the β cell mass/life cycle the individual is not yet insulin dependent, so 
the β cells are still producing insulin but it is certainly not sufficient for preventing 
hyperglycemia. The final phase of the life cycle is the β cell exhaustion phase where the patient 
becomes insulin dependent due to the β cells not being able to produce enough insulin12. The 
alpha cell also plays an intimate role with the β cell as it also makes up the islet of Langerhans. 
The α cells release glucagon that signals the liver to increase glucose production and causes a 
rise in blood glucose. α cells have been found to be in higher numbers in individuals who are 
T2DM. Signaling between α and β cells is thought to be altered in individuals with T2DM. 
Short term GC exposure  
 The β cells mass expands through hypertrophy or hyperplasia in order to overcome 
peripheral insulin resistance by increasing production of insulin. As a result of peripheral insulin 
resistance there is a detrimental effect of excess cellular glucose and lipids on the β cell that 
affects their function
80
 . Increased glucose levels result in decreased β cell survival, decreased 
insulin synthesis, and impairment of insulin signaling
81
. The effect of increased glucose on β 
cells have been well established, however very few studies have examined the direct effect of 
excess GCs on β cell function. The direct effect of GCs on β cells is thought to be highly 
temporal in nature with differing detriments for the short term and chronic timeframes. GCs 
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affect many of the same receptors in β cells as they do in skeletal muscle, thus β cells face 
similar alterations that skeletal muscles undergo in glucose transport and insulin signaling.  
 Glucose is sensed and taken up by the β cell much like it is any other cell in the body, 
through a GLUT transporter. Many diabetic models have found that a reduction of GLUT-2 
expression could be indicative of a loss of β cell function,  which results in lower glucose uptake 
and less insulin release
11
. There is evidence of insulin resistance in the periphery in these models 
but at the same time there is altered insulin release at the level of the β cell. Whether the effects 
are at the periphery or at the β cell directly, the short term effect of GCs causes expansion of β 
cell mass by what is thought to be increased β cell to cell communication within the islet. This 
was shown by Rafacho et al., where there was an increase in β cell exclusive gap junction protein 
connexon 36
82
. This increase in connexon 36 was due to just 5 days of dexamethasone treatment 
82
. In vitro studies to test the direct effect of glucocorticoids were carried out by Jeung et al. who 
exposed β cells to increasing concentrations of dexamethasone (1-100 nmol/L) over a a 6 hour 
period. The β cell function was impaired as evidenced by a significantly down regulated insulin 
synthesis levels
83
. In addition to this, Lambillotte et al. and Gremlich et al. found similar results 
in that β cells had reduced insulin secretory capacity and insulin release84. However, one 
drawback to any dexamethasone model is that it binds with ~10 fold higher affinity to the GR 
than naturally occurring GCs
11
. It is evident from the data that β cells respond differently in vivo 
and in vitro to the short term exposure to GCs. The expansion and increased glucose sensing 
ability of β cells in vivo differs in vitro where the β cells become dysfunctional in their glucose 
sensing mechanisms after short periods of dexamethasone exposure.  
Prolonged and Intermittent GC exposure to β cells  
 Prolonged treatment with a synthetic GC drug such as prednisone can cause the 
aforementioned changes in peripheral tissues such as widespread insulin resistance which 
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changes the environment (increased blood glucose and lipids) that the β cells must deal with. 
Healthy individuals that undergo prolonged GC treatment are able to resist diabetes development 
by β cell expansion and increasing glucose stimulated insulin secretion (GSIS) 85. However, 
without adequate compensation of the β cells, hyperglycemia could develop and lead to T2DM. 
The alterations in these cells that cause dysfunction and not expansion with prolonged exposure 
are thought to be due to a reduced GSIS involving the first phase insulin response. This response 
is severely blunted and appears to be due to GC affecting the calcium influx of the β cell which 
is needed for insulin secretion
11
. In addition, if the β cells cannot respond to the peripheral 
insulin resistance or increased hepatic glucose production it has been hypothesized that the cells 
become exhausted and apoptosis results
12
. It is critical to determine the time-point of β cell 
expansion or decompensation with prolonged periods of stress.  
 Diabetes has often been linked to psychological stress due to its effects on metabolic 
activity
61
. Bates et al. and Kiraly et al. focused on whether intermittent stress would act as a 
protective factor in preventing β cell loss or contribute to β cells deterioration in the Zucker 
Diabetic Fatty (ZDF) rat. Bates et al. used rat restraint stressing for 1 hr day/5 days wk/ over 
varying periods of 3, 6, or 13 weeks, to determine if intermittent stress could maintain beta cell 
compensation  in the ZDF rat. The stress resulted in increased number of islets/mm
2
 of pancreas 
after 13 wks whereas the non-stressed ZDF rats experienced a significant reduction in islet 
number compared with control rats
86
.  Kiraly et al. found similar protective effects of stress for 
the ZDF rat when the rats were stressed by being placed in water for 1 hr day/5 days wk/ 7 wks. 
The stress resulted in improved fed and fasting glucose tolerance in the stressed rats compared to 
the control animals
87
.  Additionally, the intermittent stress produced significantly higher levels of 
corticosterone in stressed ZDF rats when compared to a forced swim exercise group that 
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exercised 1 hr day/5 days wk/7wks
87
. Kiraly et al. proposed that there could have been minute 
changes in body composition such as reduced fat pad mass, that they did not account for in their 
study which could have resulted in the improved fed and fasting glucose profiles
87
. In addition 
Kiraly et al. speculated that the protective effect of stress could be due to inhibition of insulin 
secretion which would slow the beta cell decomposition process
87
.  Perhaps these intermittent 
stress regiments resulted in glucocorticoids not being chronically elevated. Thus the results seen 
in this study differ drastically from those of dexamethasone treatment effects on the β cells. To 
date there has been no study to examine the effect of CMS on a healthy animal’s islet 
morphology over a chronic timeframe. This model would differ from what Kiraly and Bates et 
al. have previously shown where the stress is applied to an animal that is progressing into overt 
diabetes through the ZDF model. An increased level of stress and perhaps longer timeframe 
could induce similar damage to that seen when synthetic GCs are administered.  
2.6 Exercise during stress and diabetes 
Exercise as medicine has become an increasingly popular theme as diabetes and obesity 
reach near epidemic levels worldwide. Exercise is a well-established means to improve blood 
glucose control in both healthy and diabetic individuals
88,89
. In further support of this, regular 
exercise training regimen in humans with T2DM has been shown to improve insulin response to 
hyperglycemia
90
.  A crucial benefit of exercise is that it has the ability to directly affect the β 
cells of the pancreas and has been shown in numerous animal models to cause an improved 
potential for insulin secretion
91–93
. Kiraly et al. demonstrated this by swim training ZDF rats for 
1 hr/day/5days/wk over a 13 week period.  Following the 13 weeks of training exercised ZDF 
rats had attenuated losses to β cells through compensation by increased β cell proliferation, new 
insulin positive clusters (neogenesis), and β cell hypertrophy 6. Although these exercise effects 
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can be seen as occurring at the level of the β cells it is important to not overlook the influence of 
exercise effects on the peripheral tissues.  
Exercise can activate GLUT-4 transporters in skeletal muscle which are stimulated via 
muscle contraction and transport glucose from the blood to the muscle which results in improved 
blood glucose maintenance. Regular exercise training leads to increased expression of GLUT-4 
in skeletal muscle, which is associated with improved insulin action and glucose metabolism. 
Furthermore, insulin sensitivity can be positively influenced by exercise training leading to 
increased signal transduction through the insulin receptor substrates 1 and 2 (IRS-1 and IRS-2) 
89
. This increased signal transduction is also important due to its role in protein synthesis and 
prevention of protein degradation. The increased IRS signaling results in the phosphorylation of 
Akt which inhibits protein degradation through repression of transcription factors of the FOXO 
family
94
. Additionally the increased phosphorylation of Akt can stimulate protein synthesis 
through mammalian target of rapamycin (mTOR) and glycogen synthase kinase 3B (GSKβ)94. 
Short term exercise is known to act as a stressor and leads to increased levels of plasma 
glucocorticoids
95
 and catecholamines
96
. However, regular exercise has proven beneficial at 
reducing perceived stress and during times of increased stress, high amounts of physical activity 
are associated with better health
97
. Exercise has been examined in human subjects with clinical 
depression and anxiety and has been shown to improve mood and lessen anxiety sensitivity
98
.     
The converse has been demonstrated among military personnel wherein increased job stress and 
psychological distress were associated with lower levels of physical activity
99
. In further support 
of stress resulting in less voluntary drive to exercise, DeVallence et al. (work not yet published) 
discovered that mice that were stressed for a 8 week period voluntarily exercised less than non-
stressed control mice. 
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Depression and anxiety are known to cause increased incidence of T2DM
7,8
. 
Additionally, stress in the form of depression and anxiety are believed to be reciprocally related 
to exercise. The studies that examine the combined effects of exercise and stress on mice are 
scarce, especially those examining the relationship between stress and exercise and there effects 
on β cell health and T2DM development. The results from the known studies focused on the 
benefits of exercise in regards to hippocampal neurogenesis, and showed marked differences 
between stressed and stress exercise animals. In one such study stressed animals exhibited 
blunted hippocampal neurogenesis while animals exposed to  exercise combine with stress 
alleviated this detrimental effect
100
. This thesis is novel and seeks to examine the combined 
effects of stress and exercise at the level of the skeletal muscle and β cells of the pancreas.  
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CHAPTER 3. STUDY DESIGN AND METHODS 
40 Male Balb/c mice were randomized into 4 groups; sedentary (N=10: Sed), sedentary stressed 
(N=10: SedSt), exercise (N=10: EX), and exercise stressed (N=10: EXSt). 20 mice were given 
free access to running wheels over 4 weeks after which, 10 were randomized to 7 hrs/d, 5 d/wk. 
of stress for 8 wks. 20 mice remained sedentary with no access to running wheels; after 4 weeks 
10 of these mice were randomized to 7hrs/d, 5d/wk. of stress for 8 wks. The varying stressors 
included bath (1.5 cm water in bottom of cage), damp bedding, no bedding, cage tilt, altered light 
cycles, and cage-switching. Exercise mice were given access to running wheels from 
approximately 3:30 p.m. to 7:30 a.m., primarily during the dark cycle. Exercise mice were also 
given access to running wheels during the weekends. Immediately after the 8th week mice were 
euthanized in CO2 chamber. Tissues were then excised and snap frozen in isopentane and placed 
into liquid nitrogen until stored at -80˚C. Immunohistochemistry staining of β cells in pancreatic 
sections were obtained using an insulin antibody to determine the number of β cells per islets and 
islet area. Muscle wet weight, real time PCR, and western blotting were used to quantify the 
effects of exercise and CMS on muscle size, atrophy gene expression, total AKT, phosphorylated 
AKT and autophagy protein expression respectively, in the gastrocnemius, plantaris, and soleus 
muscles. 
 
METHODS 
Immunohistochemisty and Imaging   
Pancreases were quickly excised from euthanized animals and immediately placed onto 2 cm x 2 
cm cork blocks and imbedded using tissue embedding medium (O.C.T. Tissue Tek) then quickly 
dipped into isopentane for 10 seconds and lastly placed into liquid nitrogen. Samples were stored 
at -80˚C until sectioning on cryostat. Sections were cut at 7 µm thickness with 25 µm in between 
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each section from the same animal. Tissue sections were traced with a Pap pen. Pap pen tracings 
were allowed 10 minutes to dry before the sections were rehydrated in PBS. Sections were fixed 
to slides by 4% paraformaldehyde in PBS, and the slides were subsequently washed in PBS for 3 
x 5 minutes. Permeabilization was in 200 mg sodium citrate in 200 ml distilled water and 200 µl 
Triton X-100 for 3 minutes at 4˚C. This was followed by another 3 x 5 minute wash in PBS. 
Goat serum (Vecta Shield) was used to block sections for 20 minutes at room temperature. 
Primary anti-rabbit Insulin antibody (Sigma) at 1:300 concentrations in PBS was incubated 
overnight at 4˚C. Primary antibodies were washed off by PBS 3 x 10 minutes. A secondary 
antibody, Alexa Fluor 546 goat anti rabbit (Invitrogen) at a 1:1000 concentration in PBS was 
applied to slides and incubated at room temperature for 45 minutes. Following the secondary 
antibodies the sections were washed in PBS 3 x 10 minutes. Hard set DAPI (Vecta shield) was 
used to stain cell nuclei and keep cover slip in place. Imaging was done using the Nikon E800 
(Nikon) microscope fitted with RT spot imaging camera (Diagnostic Instruments). Images were 
viewed on computer monitor and taken as single images of the illuminated Alexa Fluor 546 or 
DAPI and merged using Spot Advanced imaging software package (Diagnostic Instruments). 
 
Islet morphology and Beta Cell counting 
Approximately 200 islets from each group were analyzed and βcells counted individually from 
each islet using Image J. Image J was also used to determine the area of each islet in arbitrary 
units and normalized to total pancreatic section area.  The islets were categorized for each group 
by average size; grouping small, medium, and large islets. Average numbers of β cells per islet 
area were calculated for each group.  
Western Blot Analysis 
Whole muscle samples of the gastrocnemius were homogenized using a lysis buffer. Coomassie 
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(Bradford) protein assay was conducted to acquire the protein concentrations for loading samples 
prior to gel electrophoresis. Loading samples were generated for Western Blot at 75µg/µL. 30µL 
of loading samples were subjected to gel electrophoresis in 4-12% bis-tris (NuPage) gel at 200 
volts. The gel was then transferred to a nitrocellulose membrane at 4°C for 2:20 hours at 170mA 
in transfer buffer. The membranes were cut into strips at the molecular weights corresponding to 
MuRF1, MAFbx, ATG-7, ATG-12, Beclin-1, AKT, pAKT and GAPDH. Strips were 
subsequently blocked in 2% non-fat dry milk blocking solution for 1 hour prior to incubating 
overnight with gentle rocking at 4°C in primary antibodies for MuRF1, MAFbx, ATG-7, ATG-
12, Beclin-1, AKT, pAKT and GAPDH. Following overnight incubation, membranes were 
washed 3x in TBST for 5 minutes each. After washing, secondary anti-rabbit HRP linked 
antibodies (1:1000) were applied to the membrane and incubated at room temperature for 1 hour. 
Membranes were then washed 4 times for 15 minutes in TBST prior to applying ECL and 
imaged using the GBOX (Syngene). 
Real Time PCR  
RNA was extracted from 1/5 of the mid-belly of the gastrocnemius muscle using 500 uL of 
TRIzol reagent and a hand held homogenizer. Homogenate was incubated for 10 minutes at room 
temperature then 140 uL of chloroform was added, then vortexed and centrifuged at 4˚C for 15 
minutes 12000 RCF. Supernatatant was removed and placed in 1.5 ml RNAse free tube. RNeasy 
kit (Quiagen) was used for the remaining steps of the RNA extraction. Digestion of DNA was 
done by adding 0.1 x vol. RNA to 1 µl of DNAse I –incubated at 37˚C for 30 minutes, then 
adding 0.1 x vol DNase inactivation reagent and incubated at room temp for 2 minutes. The 
mixture was centrifuged for 90 seconds at 10000 RCF.  One microgram of total RNA was then 
reverse transcribed using Superscript Vilo according to the manufacturers protocols (Invitrogen). 
PCRs were performed by using SensiFAST SYBER HI-ROX (Bioline) kit according to the 
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manufacturer’s instructions. The following primer sets were used in PCRs:  murf-1, zfand5, 
atrogin-1, fbxo3, bard1, ube2d1, ubez2, ube4a, fbx120, torpors, nedd41. GAPDH primers were 
used as a sample normalizer.  260/280 values  were quantified using Nano Drop. RT-qPCRs were 
performed on an Mx 3005p Real Time PCR system (Stratagene). The temperature cycle profile 
for the qPCR reactions was 95 °C for 15 min and 40 cycles of 94 °C for 15 s, 55 °C for 30 s, and 
72 °C for 30 s. Melting curve analysis was also included at one cycle of 95 °C for 1 min, 55 °C 
for 30 s, and 95 °C for 30 s to verify the specificity of the amplified PCR products. The amount 
of amplified transcripts (2 CT) was estimated by the comparative CT method and normalized to 
an endogenous reference (GAPDH) relative to a calibrator. All PCR products were verified on 
agarose gel stained with ethidium bromide to discriminate between the correct amplification 
products and the potential primer dimers. 
 
Statistical Analysis  
All data are represented as a mean ± SE, with a criterion of P < .05 and were assessed using one 
–way and two-way ANOVAs as a means of statistical significance. Individual differences were 
evaluated using Tukey’s HSD post hoc test (GraphPad Prism 4.0 software) with adjustments 
made for multiple comparisons.  
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CHAPTER 4. RESULTS  
 
Body Weights  
The body weights of the stressed mice were not significantly different from that of the control 
mice over the entirety of the 8 week study (Figure 1). The exercise stressed mice had 
significantly increased body weights when compared to the exercise only mice with the 
significant differences not occurring until 4 weeks into the stress period (indicated on graph by 
black box). (Exercise 25.75 g ± 1.08; Exercise Stress 27.28 g ± 1.16) These two groups remained 
significantly different from week 8 until the end of the study (Figure 1. P < .05) Exercise only 
mice also had significantly decreased body weights compared to the sedentary mice at week 11 
and at the end of the study (Figure 1. P < .05). Additionally at the end of the study the exercise 
only mice had a significantly decreased body weight compared with the stressed mice (Figure 1. 
P < .05). 
Distance and Time spent running  
The exercise stressed mice spent significantly less time running and ran an average of 3.2 km 
over the course of the 8 week stress period, as compared to the distance run by the exercise only 
mice which averaged 4.4 km (Figure 2. P < .05). Additionally, the exercise stressed mice spent 
less time running compared to the exercise only mice (Exercise Stressed 157 minutes; Exercise 
212 minutes; Figure 2. P < .05).        
Muscle Morphometrics 
Muscle wet weight was used to determine if stress or exercise or the combination of the two 
would result in any significant changes in the mass of the hindlimb muscles; specifically the 
gastrocnemius, soleus, and plantaris. Muscle wet weights (mg) were normalized to body weight 
(g). Significant differences occurred between the Exercise mice and the Sedentary mice with the 
exercise mice showing an 11.43% increase in the wet weight of the gastrocnemius muscle and an 
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18.84% increase in the wet weight of the plantaris (Figure 3, P < .05). The plantaris weight of the 
Exercise only mice also was increased compared to the Sedentary Stressed mice (Figure 3, P < 
.05). Additionally the Exercise Stressed mice had significant increases of the normalized 
gastrocnemius wet weight (13% and 15%) and plantaris wet weight (29% and 24%) compared to 
the Sedentary and Sedentary Stressed mice, respectively (Figure 3, P < .05). No significant 
differences were seen in the weight of the soleus between any of the groups. Absolute muscle 
weights of the gastrocnemius and the plantaris were only increased in the Exercise Stressed 
group (Table 1). There was no absolute muscle wet weight difference between the Sedentary, 
Sedentary Stressed, and Exercise mice when examined for gastrocnemius, plantaris, and soleus. 
However, the Exercise Stressed mice had increased absolute muscle wet weight of the 
gastrocnemius when compared to Sedentary, Stressed, and Exercise only mice. (Table 1, P< 
.05).   
Mean β cell number per islet 
The mean number of β cells per islet was examined by counting individual DAPI stained β cells 
within the insulin stained positive area. Compared to the Sedentary mice both the Stressed and 
Exercise Stressed mice had a higher mean number of β cells per islet (Sedentary, 70.73 ± 4.77; 
Stressed 90.99 ± 5.22; Exercise Stressed 93.21 ± 5.69, Figure 4. P < .05). The Stressed and 
Exercise Stressed mice also had a higher mean number of β cells when compared to the Exercise 
only mice (Exercise 68.64 ± 3.73; Stressed 90.99 ± 5.22; Exercise Stressed 93.21 ± 5.69, Figure 
4. P < .05).  
Mean Islet area  
Islet morphology was investigated by insulin positive staining. The insulin positive area in the 
Exercise Stress increased 29.05% when compared to their Exercise alone counterparts (Figure 5, 
P < .05). The Sedentary Stressed mice had an increased islet area compared to the Exercise only 
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mice, however this increase was not significant (Stressed 22445.92 ± 1488.67; Exercise 
18770.16 ± 1187.19; Figure 5, P=.14). Representative images of the islets from each group 
stained with insulin (red) and DAPI (blue) can be seen in figure 6.  
 
Muscle Specific atrophy gene expression  
The relative gene expression of the muscle specific atrophy genes was not significantly different 
between any of the groups for either Murf-1 of Mafbx (Figure 7).   
 
Ubiquitin Proteolysis gene expression  
Ubiquitin proteolysis relative mRNA expression was significantly different between multiple 
groups for the genes Nedd41 and Topors. Topors relative expression levels were significantly 
reduced in the Exercise and Exercise Stressed groups compared to both the Sedentary and 
Sedentary Stressed mice (Figure 8. P < .05). Nedd41 realtive mRNA expression was 
significantly reduced in the Exercise mice when compared to both the Sedentary and Sedentary 
Stressed mice (Figure 8. P < .05). Interestingly, the Exercise Stress mice had increased levels of 
Nedd41 mRNA expression when compared to the Exercise mice (Figure 8. P < .01).   
E3 Ubiquitin Ligase protein abundance  
Maf-bx protein expression levels were not consistently expressed clearly and reliably thus there 
was no quantification available aside from the mRNA data. MURF-1 protein abundance was not 
significantly different between any of the groups (Figure 9).  
Autophagy protein abundance  
Autophagy was measured by the proteins Beclin-1, ATG-7, LC3a isoform and LC3b isoform. 
Beclin-1 was significantly reduced in the Exercise Stressed group when compared to the 
Sedentary mice (Figure 10. A, P < .05). ATG-7 remained unchanged across all groups (Figure 
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10. B). The LC3a isoform was unchanged across all groups (Figure 10. C). The LC3b isoform 
was significantly increased in the Exercise Stressed mice when compared with the Sedentary 
mice (Figure 10. D, P < .05).  
 
Mouse Coat States  
Although the coat states of the mice were not consistently quantified, observations on a subset of 
mice indicated that the stressed mice had deteriorating coat conditions over the course of the 8 
week study. Additionally stressed mice were visibly more agitated and aggressive when being 
handled as compared to the sedentary non-stressed mice.  
Total AKT and pAKT protein abundance  
Following the discovery that the muscle had not undergone atrophy in the Exercise Stressed mice 
and the wet weights were actually increased, the total AKT and pAKT protein levels were 
examined by western blotting to further elucidate a cause for the increased muscle weight. Both 
the total AKT and the pAKT protein abundance levels were significantly increased in the 
Exercise Stressed mice when compared to the Sedentary mice (Figure 11 A&B, P < .05).  
 
CHAPTER 5. DISCUSSION 
 The central aim of this thesis was to determine the effects of chronic stress alone and in 
combination with exercise on murine β cell morphology and skeletal muscle atrophy gene 
expression, ubiquitin proteolysis gene expression, and protein markers of autophagy expression. 
The central hypothesis was that a CMS protocol of 8 weeks would result in the expansion of the 
β cells resulting in an increased insulin positive area and additionally would result in the atrophy 
of the hind limb skeletal muscle through up-regulation of skeletal muscle specific atrophy genes 
Murf-1 and Mafbx along with up-regulation of ubiquitin proteolysis genes. The introduction of 
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voluntary wheel running in combination with CMS was hypothesized to result in the attenuation 
of β cell expansion and the attenuation of skeletal muscle atrophy as measured by the normalized 
wet weight of the muscle and atrophy gene expression. The main finding of this thesis was that 
CMS resulted in a significant increase in β cells per islet and mean insulin positive area with or 
without exercise. Furthermore, 8 weeks of CMS did not result in muscle atrophy, but in fact 
resulted in significant increases in normalized muscle wet weight when compared to Sedentary 
mice. The use of CMS in combination with voluntary wheel running is unique and these findings 
are novel.   
 Initially we set out to determine if there was any β cell loss in the Islets of Langerhans 
due to increased apoptosis as indicated by TUNEL staining. Butler et al. reported that human 
T2DM patients showed a decreased β cell mass due to apoptosis3. However, our findings 
demonstrated that 8 weeks of CMS was not a great enough insult or long enough to result in a 
loss of β cell mass through increased β cell apoptosis (observational data). 
 The life cycle of β cells in patients with T2DM has been elegantly summarized by Weir 
and Bonner-Weir15. We believe that the level of stress used in the present study resulted in what 
Weir and Bonner-Weir term as stage 1 and stage 2 of the progression of β cell dysfunction. Stage 
1 is defined as the compensation phase with expansion of the islet cells and the stable adaptation 
of these cells. Stage 2 is the completion of this expanded state15. Our data support this in that the 
chronically stressed mice showed an increased insulin positive islet area and an increased 
number of β cells per islet (Figure 4 &5). This finding is similar to that of Kiraly et al. in which 
ZDF rats were intermittently stressed, resulting in β cell expansion6. The ZDF rats in the study 
that were not stressed had decreased islet areas and decreased numbers of β cells per islet6. As 
mentioned previously, there was no significant increase in the level of β cell apoptosis in our 
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Stressed mice when compared to the Sedentary controls. Therefore, it would appear that the 
Stressed mice had not reached the decompensation phase of β cell dysfunction resulting in β cell 
loss.  
The insulin positive area for the Exercise group was unchanged from that of the 
Sedentary mice (Figure 5). However, when mice were stressed and also voluntarily exercised 
over an 8 week time period, the insulin positive area expanded significantly to levels greater than 
that of the Stressed only mice. Exercise has been shown to produce a higher insulin content of 
islets and higher glucose stimulated insulin secretion in isolated rodent islets9. Our data show 
that the combined effect of stress and exercise resulted in an insulin positive area expansion and 
an increase in the number of β cell per islet (Figures 4 &5). This expansion can be seen as a 
healthy response in the exercise stressed mice as the system adapts to an increase in the amount 
of circulating glucocorticoids and glucose; which has been shown to occur independently with 
exercise and stress11. Hyperglycemia can be prevented by increasing the number of β cells and 
thus having more insulin available for release. Similarly with stress alone, the islet expansion 
during the 8 weeks of stress cannot be viewed as a maladaptation2. Although we did not measure 
blood glucose or corticosterone, the islet expansion observed in the stressed mice provides 
speculative evidence that the corticosterone levels were elevated and caused the expanded insulin 
positive area and increased β cells per islet. Increased β cell number and area has been previously 
demonstrated in rats following 24 days of dexamethasone administration8. Fewer than 20% of 
these animals became diabetic and rats that were able to maintain healthy blood glucose levels 
did so by increased insulin secretion8. Our results mirror this β cell expansion and we speculate 
that our animals were able to maintain euglycemia through expansion of the islets and an 
increase in β cell number.    
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 CMS had no effect on the muscle wet weights of the stressed mice. There were no 
significant differences between Stressed and Sedentary mice for muscle weight normalized to 
body weight or absolute muscle weight (Figure 3 and Table 1). This is contrary to much of the 
literature in which exogenous glucocorticoids either injected or delivered via subcutaneous 
osmotic mini pump resulted in muscle proteolysis10,14. The atrophy previously observed could be 
the result of the synthetic glucocorticoid dexamethasone, which has a much higher affinity for 
the glucocorticoid receptor when compared to natural corticosterone.  However, to our 
knowledge no literature has analyzed muscle from a mouse subjected to a CMS protocol. 
According to our data the stress resulted in a change in insulin positive area of the pancreas, but 
did not cause skeletal muscle atrophy (Figure 3). A possible explanation could be that the CMS 
protocol used in the present study was insufficient to cause the necessary increase in circulating 
glucocorticoids that result in muscle atrophy. The levels of circulating glucocorticoids may not 
have reached sufficient levels to block protein synthesis and upregulate protein catbolism11,14. 
Another possibility could be that islet expansion and increased insulin availability prevented 
skeletal muscle protein degradation and therefore overall muscle atrophy. Insulin has been 
shown to have an anti-catabolic effect when administered in vitro to myocytes and L8 
myoblasts4. Additionally insulin injection has been shown to antagonize the effects of 
glucocorticoids on myofibrillar protein balance in rats13. The increases in insulin positive area 
and the glucocorticoids ineffectiveness to cause atrophy in the hindlimb muscle, may have been 
the result of an insulin to corticosterone ratio that was anti-catabolic or even anabolic for the 
muscle (Figure 3). The increase in insulin availability combined with voluntary exercise 
appeared to result in a protective effect of the muscle, leading to a greater wet weight.  
 Muscle specific atrophy gene expression was not affected by either stress or exercise. 
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These results are consistent with the previous explanation that either the stress protocol was not 
sufficient enough, the mice had become habituated to the stress, or that circulating insulin was 
high enough to prevent the anti-anabolic or catabolic action of glucocorticoids12. The mRNA 
relative expression levels of the atrogenes MuRF-1 and MAFbx were not significantly increased 
in the Stressed mice and were unchanged across all groups (Figure 7). However, genes involved 
in the ubiquitin proteasome pathway were significantly decreased in the Exercise mice (Figure 
8). Reduced expression levels of Topors and Nedd41 when compared to Sedentary and Stressed 
mice demonstrated that the Exercise only mice possibly had decreased protein degradation 
occurring within their skeletal muscle. However, Nedd 41 did show an increased relative 
expression in the Exercise Stressed mice when compared to Exercise mice.  This may indicate 
that exercise alone was able to reduce the level of protein degradation as measured by this gene 
but was unable to do so when the animals were stressed.  The mice that underwent CMS alone 
had no change in these protein degradation pathway genes which leads us to believe that the 
stress was not great enough to result in muscle atrophy.   
 The relative protein abundance of the atrogenes was similar with the mRNA data in that 
no significant changes occurred between the groups (Figure 9). We had a difficult time with the 
MAFbx antibody and getting it to reliably show up on the blots, therefore the data were 
excluded. (Supplemental Figure 2) 
Skeletal muscle autophagy, measured by Beclin-1, ATG-7 and LC3a/b protein abundance, 
indicated an increased level of autophagy for the Exercise Stressed mice when compared to the 
Sedentary mice based upon the significant increase in the LC3b isoform, which is a final effector 
in autophagosome formation 72(Figure 10D). However, the abundance of Beclin-1, which 
initiates autophagy through complexation with various autophagy proteins (Atg14, Vps15, 
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UVRAG, Rubicon, class III PI3K) was significantly increased in the Sedentary mice when 
compared to the Exercise Stressed mice (Figure 10 A). A possible explanation could have to do 
with the amount of time elapsed from the last bout of exercise to sacrifice. Kim et al. found that 
muscle abundance of Beclin-1 protein was significantly decreased immediately post exercise 
when compared with sedentary controls5. The Exercise Stressed mice, which had access to 
running wheels, could have exercised right up until the time of sacrifice. This could be a possible 
explanation as to why we saw the significant decrease in Beclin-1 protein in the Exercise 
Stressed group. Additionally this explanation comes into play when evaluating the protein 
abundance of the LC3a isoform and LC3b isoforms. The LC3a isoform was unchanged across all 
groups; however the LC3b isoform, which when increased, is indicative of complete phagophore 
formation, was significantly increased in the Exercise Stressed mice (Figure 10 D).  The last bout 
of exercise may have occurred within hours of sacrifice which could have caused the increased 
level of the LC3b isoform. Kim et al. also examined the LC3 a/b isoforms following exercise and 
concluded that protein abundance of the LC3a isoform is reduced when compared to non-
exercising controls immediately following exercise5. However, when Kim et al examined the 
LC3b isoform, it was non-significantly increased in the mice that were sacrificed immediately 
following exercise when compared to controls 5. Our data showed that the combination of 
exercise and stress caused an elevation in the protein abundance of the LC3b isoform while 
having no effect on the protein abundance of the LC3A isoform (Figure 10 C&D).  
 Body weights were not significantly different between the Sedentary and the Sedentary 
Stressed mice; however significance did occur between the Exercise and Exercise Stressed mice, 
with the latter having a greater body mass after 4 weeks of stress (Figure 1). Previous studies 
have demonstrated that a chronic stress protocol can result in a depressed like state in mice and a 
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decreased body weight after just 4 weeks of chronic stress13. A possible explanation for the lack 
of weight loss observed in our stressed mice could be related to the strain of mouse used in our 
study. Schweizer et al. showed significant body weight differences in the stressed D2OIa mice 
and BL/6J mice compared to their non-stressed counterparts, with the stressed mice gaining less 
weight over the course of the 10 week study13. Additionally, Schweizer et al. demonstrated a 
sucrose preference difference between strains of mice, a key metric used in the determination of 
anhedonia13. Sucrose preference returned to baseline levels at the end of the study in the Balb/c 
strain13. Schweizer et. al demonstrated that Balb/c mice appeared to be able to adapt better to 
stress compared to other strains. This may be a reason why the chronic stress protocol used in the 
present study did not result in as many significant detrimental effects as we would have expected 
to see. Conversely, the enhanced insulin positive area and greater β cell number seen in the 
exercise stressed mice may have led to a general anabolic state due to greater circulating insulin 
levels. Although speculative, this may have provided the necessary hormonal environment to 
cause increased growth and body weight.   
 Laboratory records indicated that the stressed mice demonstrated poor grooming of their 
coats with thin, patchy, and dirty coats. Additionally, stressed mice had red conjunctivae which is 
a common occurrence in mice subjected to chronic stress17. The lab notes, although not 
completely qualitative, provide us with some evidence of the levels of stress that the mice were 
experiencing. A sign that the mice were stressed was that the stressed mice did not voluntarily 
run as much as the mice that were not being stressed (Figure 2) (unpublished data from 
DeVallence et al.) Previous research has shown that when mice experience increased levels of 
stress, it resulted in them being less active than their non-stressed counterparts12. However, it is 
important to take into consideration that much like in humans, hypoactivity and hyperactivity can 
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occur in depressive like states16. This has been demonstrated by Mineur et al. who used multiple 
strains of mice to determine the effects of CMS17. This study demonstrated that particular strains 
respond to CMS through hyperactivity while others respond through hypoactivity, and the 
method of the behavioral testing can influence activity based on the strain of the animal as well.  
 The total AKT and pAKT levels were examined when it was discovered that the 
gastrocnemius and plantaris from the Exercise Stressed mice had increased wet weight and that 
the atrogenes were not upregulated in the Sedentary Stressed mice. Both the total AKT and 
pAKT levels were increased in the Exercise Stressed mice when compared with the Sedentary 
Stressed mice (Figure 11A & B). An elevated phosphorylation of AKT (Figure 11B) may indicate 
an increase in insulin signaling and perhaps further downstream increases in protein synthesis 
and inhibition of protein degradation in the gastrocnemius and plantaris of the Exercise Stressed 
mice94.  
     
Limitations and Future Directives  
A large limitation of this study is the lack of plasma levels of corticosterone, insulin, 
glucose, and glucagon. We have provided a limited glimpse into a model that we believe results 
in hyperinsulinemia and elevated corticosterone based on previous research6,9 and our data of β 
cell expansion in number and of insulin positive area in stressed animals. A single blood sample 
measure of corticosterone would have provided very little information because of the large 
diurnal release of this hormone. Quantifying changes in circulating corticosterone is difficult and 
requires multiple samples taken over multiple days collected at the same time of day. Including 
this information would have given us an idea as to how the stress affected the diurnal nature of 
corticosterone release and if the levels would be comparable to that seen in mice that have 
demonstrated muscle atrophy with injected corticosterone or dexamethasone. Future studies 
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should examine these factors to determine if exercise has a beneficial effect on plasma insulin 
levels and corticosterone levels when animals are subjected to chronic stress.  
In order to determine a pathway for the expansion of insulin positive area and increased β 
cell number per islet, β cells of the pancreas should have been isolated from half of our animals, 
with the other half of the animals having their pancreas used for IHC. The glucose stimulated 
insulin release and the insulin content of the β cells could have been measured in order to 
understand the effects of stress and/or exercise on the β cells. Additionally the GLUT-2 receptor 
could have been examined through western blots of these isolated cells as it has been shown to 
have reduced  protein expression in diabetic models where there is also a loss in β cell 
function101. Although we believe our β cells were still in the compensation phase it would have 
been interesting to examine the endoplasmic reticulum stress pathway as it has been implicated 
in β cell death in T2DM1. These measures would have provided the study with functional 
measures and other pathways that could be the cause of the functional changes.  
An initial aim of this thesis was to examine the β cell to α cell ratio and determine if 
stress resulted in an increase of α cells as has been observed in T2DM humans13. This goal was 
not achieved due to the antibody for glucagon not providing a reliably accurate stain of the α 
cells. The exact cause of this poor staining is unknown, however we were using a mouse 
antibody on a mouse tissue and therefore the result was a large amount of non-specific binding 
and inconclusive results. Future studies should examine this along with the β cell morphology to 
determine if there is an irregular rise in the number or area of glucagon positive α cells. Plasma 
levels of glucagon would also need to be determined in order to further elucidate the stress 
effects on the mouse pancreas and overall endocrine dynamics of mice faced with chronic stress.  
In order to determine if the muscle weight gains discussed previously were completely 
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accurate, a better way to determine enhanced growth would have been to use the cross sectional 
area of the gastrocnemius. Muscle morphometrics could have also been determined by fiber size 
of laminin immunohistochemically stained muscle sections. Muscle wet weights are a crude 
measure of muscle size, but in the case of this study where inflammation could have played a 
role in the increased weight of the muscle, wet weight might not have been the greatest choice. 
Further examination of protein synthesis elements, which are additionally involved in insulin 
signaling such as mTOR, 4E-BP1, and p70SK6 would have provided further evidence as to 
whether the muscle gains observed are true gains or possibly a byproduct of muscle 
inflammation. Additionally, the autophagy protein data at the level of the muscle should have 
been from muscles that were extracted with the knowledge of exactly when the last bout of 
exercise occurred. This would have provided the most accurate representation of the levels of 
autophagy which could have been occurring due to either the stress, exercise, or both.   
We needed to more accurately record the daily changes in the mice coat state and provide 
an additional measure of behavioral patterns to determine the magnitude of stress over time. This 
measure would have allowed us to better understand the level of stress the animals were 
experiencing throughout the 12 week study.    
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Figure Legends 
 
Figure 1. Mouse body weights in (g) over the course of the 12 week study with the stress 
beginning at week 4. N=10 for each group. * P < .05 compared to Sedentary, † P < .05 
compared to Sedentary Stressed, # P < .05 compared to Exercise only. All data are represented as 
a mean ± SE 
 
Figure 2. Mean run time and mean total distance run per day over the 8 week exercise period for 
Exercise and Exercise Stress mice. N= 10 for each group. All data are represented as a mean ± 
SE.  # P < .05 compared to Exercise only  
 
Figure 3. . Muscle wet weights of gastrocnemius, plantaris, and soleus (mg) were normalized to 
body weight (g). N=10 for each group. * P < .05 compared to Sedentary, † P < .05 compared to 
Sedentary Stressed. All data are represented as a mean ± SE 
 
Table 1. Absolute muscle weight recorded in mg from each group for the gastrocnemius, 
plantaris and soleus muscles. N=10 for each group. * P < .05 compared to Sedentary, † P < .05 
compared to Sedentary Stressed, # P < .05 compared to Exercise. All data are represented as a 
mean ± SE   
 
Figure 4.  β cell number in Sedentary Stress and exercise stress mice were significantly 
increased compared to the Sedentary group (P < .05). Sedentary Stress and Exercise Stress 
groups were also significantly increased compared to the exercise group (P < .05). * P < .05 
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compared to Sedentary, # P < .05 compared to Exercise. Representative images can be seen in 
Figure 3. All data are represented as a mean ± SE. 
 
Figure 5. Insulin positive area is increased when Stressed mice are allowed to voluntarily 
exercise at night. Area was significantly increased in Exercise Stressed mice vs Exercise only 
mice (P < .05). # P < .05 compared to Exercise. N=125-209 islets for each group. 
Representative images can be seen in Figure 3. All data are represented as a mean ± SE.  
 
Figure 6. Representative islet images from Sedentary, Sedentary Stressed, Exercise, and 
Exercise Stressed mice stained for Insulin (red) DAPI (blue).  
 
Figure 7. qPCR was used to evaluate the relative expression of muscle atrophy specific genes 
MuRF-1 and MAFbx. The expression levels were not significantly different among the groups. 
N= 3 for each group. All data are represented as a mean ± SE. 
 
Figure 8. qPCR relative expression levels for ubiquitin proteolysis genes Nedd4-1 and Topors. 
N= 3 for each group. * P < .05 compared to Sedentary, †P < .05 compared to Sedentary 
Stressed, # P < .05 compared to Exercise. All data are represented as a mean ± SE.   
 
Figure 9. MuRF-1, muscle specific atrophy protein expression in the gastrocnemius muscle with 
western blot image and quantification N=10 for each group. MuRF-1 protein levels were 
expressed relative to GAPDH. All data are represented as a mean ± SE.   
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Figure 10. Autophagy-related protein expression in gastrocnemius muscle with western blot 
image and quantification of autophagy protein for Beclin-1 N=7 for each group (A) ATG-7 N=8 
for each group. (B), LC3a N=8 for each group (C) LC3b N=8 for each group (D). All autophagy 
related protein levels were expressed relative to GAPDH. * P < .05 compared to Sedentary. All 
data are represented as a mean ± SE   
 
Figure 11. The total AKT protein expression of the gastrocnemius muscle from Sedentary, 
Stressed, Exercise, and Exercise Stressed mice (A) N=2 for each group. † P < .05 compared to 
sedentary stressed. The phosphorylated AKT protein content of the gastrocnemius muscle from 
Sedentary, Stressed, Exercise, and Exercise Stressed mice (B) N=2 for each group. † P < .05 
compared to sedentary stressed. All data are represented as a mean ± SE.   
Supplemental Figure Legends  
Supplemental Figure 1. Relative mRNA expression of ubiquitin proteolysis associated genes. 
N= 3 for each group. There are no significant differences between any of the groups for all the 
genes measured. All data are represented as a mean ± SE.    
Supplemental Figure 2. A representative western blot image of the MaFbx protein; the arrow is 
pointing to the upper faint band at 42 kDa. The lower band is that of Murf-1 at 40 kDa, which 
was nonspecifically bound by the Mafbx antibody.  
Supplemental Figure 3. Islet size distribution in % of islets per size grouping (A.U.) N= 122-
209 for each group.    
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Figure 10 C. 
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Figure 10 D.  
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Table 1. Absolute Muscle Weights (mg)  
 Sedentary Stress Exercise Exercise Stress 
Gastrocnemius 145.81 ± 
4.4127 
 
148.55 ± 
3.3269 
 
148.05 ± 
4.9532 
 
 
168.08 ± 
3.0865 
* # † 
 
Plantaris 19.14 ± 
0.7442 
 
18.37 ± 
0.6723 
 
21.37 ± 
0.7987 
 
23.82 ± 
0.8786 
 
Soleus 9.76 ± 
0.4099 
 
9.23 ± 
0.6680 
 
9.93 ± 
0.7142 
 
10.70 ± 
0.7314 
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Supplemental Figures  
Supplemental Figure 1 
 
GENE  FUNCTION  
Fbx03 Fbox protein family, involved in phosphorylation dependent ubiquination  
Bard1 Mediates E3 ubiquitin ligase activity  
Ube2d1  Ubiquitin dependent protein catabolic process  
Ubez2  E3 ubiquitin ligase  
Ube4a  Catalyzes ubiquitin chain assembly in conjunction with E1, E2, E3  
Fbx120  E3 ubiquitin ligase  
Zfand  Involved in protein degradation via the ubiquitin proteasome system.  
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Supplemental Figure 2  
 
MaFbx       
GAPDH                                                                                                                                                                                                                                                                                                                                                                                                                                               
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
68 
 
Supplemental Figure 3  
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Appendix   
Glucocorticoids  
GC released from the adrenal cortex, namely cortisol (in humans) or corticosterone (in 
rodents) are the end point of the HPA and are steroid derived hormones with wide ranging 
effects
102
. Upon their release into the circulation GC’s are influenced by corticosteroid binding 
globulin (CBG) which binds over 90% of circulating glucocorticoids. Circulating GCs are also 
influenced by 11 B hydroxysteroid dehydrogenase which exists in two forms (1 and 2) and 
interconverts GC’s into their active or inactive forms respectively59. GC’s are one of the most 
commonly used anti-inflammatory and immunodulatory agents
103
.They are mainly known for 
their anti-inflammatory effects, but are also widely used to treat immune disorders, allergies, and 
allograft rejection
104
. The anti-inflammatory and metabolic effects of glucocorticoids are 
mediated through their binding to their specific receptor which remains in an inactive form and 
resides within the cytoplasm of target cells
105
. The inactive GR is stabilized and forms large 
heterotrocomplexes with heat shock protein 90 (hsp90) and other heat shock proteins
106.  GC’s 
binding to its receptor causes activation and results in a change in the GR conformation and 
hyperphosphorylation
107
.  Activated receptor translocates to the nucleus, binds to DNA, and 
alters transcriptional target genes
107
 
104
. The binding to the glucocorticoid response element 
(GRE) results in increased production of anti-inflammatory proteins including lipocortin-1, 
interleukin-10, and interleukin-1
104
. In addition, the GRE binding has the ability to interfere with 
the DNA binding activity of NF-KB which is a major pro-inflammatory transcription factor
107
.  
GCs have many essential functions throughout the body and without them an organism 
cannot survive. As an organism is faced with stressful stimuli (starvation, pain, trauma, stress, 
heat/cold) GCs are released from the HPA axis and serve to reduce the harmful results of these 
stressful stimuli
107
. They do this through alterations in metabolism, immune function and 
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behavior. It has been hypothesized by Munck et al. that this occurs in order to suppress our 
natural defense mechanisms rather than to enhance them. They propose that the purpose of GCs 
is to not respond to the stress itself but to lower normal defense mechanisms that are turned on 
during stress and in doing so elicit protection from their harmful effects.
108
. When homeostasis 
does become threatened due to stress or hypoglycemia, the primary metabolic action of GC is 
stimulation of hepatic gluconeogenesis
108
 causing increased release of glucose into circulation. 
Further metabolic alterations occur as GCs decrease the uptake and utilization of glucose at 
peripheral tissues. Hornbrook et al. also found that GCs influence insulin signaling and cause 
decreases in the levels of IRS-1 which results in decreased glucose uptake. This results in a rapid 
rise in blood glucose and glucose availability to exercising muscles.   
GCs also influence immune and inflammation pathways. As discussed previously, GCs 
cause the increased transcription of genes that would inhibit the synthesis, release, or efficacy of 
cytokines that promote immune or inflammatory reactions
108
. The inflammatory mediators are 
also inhibited by GCs such as histamine, bradykinin, eicosanoids , nitric oxide, elastase and 
plasminogen activator
109110,111
. Lastly GCs can elicit their response neurobiologically and 
through changes in behavior. GCs inhibition of glucose transport and utilization also occurs in 
the brain as it does in peripheral tissues
112,113
. In addition, GCs cause behavioral changes related 
to food intake. Cohn et al found that adrenalectomy rats had decreased feeding and food seeking 
behavior but this was reversed with GC administration. Interestingly and in further support of 
this, appetite peaks usually coincide with circadian GC cycle peaks
114
.Evidence is increasing that 
chronic stress and chronic activation of GCs become detrimental to the organism, possibly 
leading to the onset of inflammatory/autoimmune disease, psychiatric disorders and metabolic 
disorders such as metabolic syndrome and diabetes
59
.  
